JP2014501524A5 - - Google Patents

Download PDF

Info

Publication number
JP2014501524A5
JP2014501524A5 JP2013545306A JP2013545306A JP2014501524A5 JP 2014501524 A5 JP2014501524 A5 JP 2014501524A5 JP 2013545306 A JP2013545306 A JP 2013545306A JP 2013545306 A JP2013545306 A JP 2013545306A JP 2014501524 A5 JP2014501524 A5 JP 2014501524A5
Authority
JP
Japan
Prior art keywords
dehydrogenase
pqq
formula
aldose
reaction system
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013545306A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014501524A (ja
JP6194251B2 (ja
Filing date
Publication date
Priority claimed from EP10015774A external-priority patent/EP2465936A1/en
Application filed filed Critical
Priority claimed from PCT/EP2011/073412 external-priority patent/WO2012095244A2/en
Publication of JP2014501524A publication Critical patent/JP2014501524A/ja
Publication of JP2014501524A5 publication Critical patent/JP2014501524A5/ja
Application granted granted Critical
Publication of JP6194251B2 publication Critical patent/JP6194251B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013545306A 2010-12-20 2011-12-20 医薬品有効成分およびこれの中間体の酵素的合成 Expired - Fee Related JP6194251B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP10015774.2 2010-12-20
EP10015774A EP2465936A1 (en) 2010-12-20 2010-12-20 Enzymatic synthesis of statins and intermediates thereof
EP11168227 2011-05-31
EP11168227.4 2011-05-31
PCT/EP2011/073412 WO2012095244A2 (en) 2010-12-20 2011-12-20 Enzymatic synthesis of active pharmaceutical ingredient and intermediates thereof

Publications (3)

Publication Number Publication Date
JP2014501524A JP2014501524A (ja) 2014-01-23
JP2014501524A5 true JP2014501524A5 (enExample) 2016-06-30
JP6194251B2 JP6194251B2 (ja) 2017-09-06

Family

ID=45529045

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013545306A Expired - Fee Related JP6194251B2 (ja) 2010-12-20 2011-12-20 医薬品有効成分およびこれの中間体の酵素的合成

Country Status (7)

Country Link
US (1) US20130337485A1 (enExample)
EP (1) EP2655650B1 (enExample)
JP (1) JP6194251B2 (enExample)
CN (1) CN103403174B (enExample)
AU (1) AU2011355209B2 (enExample)
CA (1) CA2822331A1 (enExample)
WO (1) WO2012095244A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2210935A1 (en) * 2009-01-19 2010-07-28 Deinove Methods for isolating bacteria
CN110592249A (zh) * 2019-10-29 2019-12-20 山东省果树研究所 一种快速鉴定果园高效解磷细菌的特异性引物及其试剂盒、分离鉴定方法
CN113373187B (zh) * 2021-05-26 2023-11-10 江苏阿尔法药业股份有限公司 一种氮杂环化合物c27h30fno6的酶催化合成方法
CN114045243B (zh) * 2021-12-03 2023-12-26 山东天力药业有限公司 一种缩短生黑葡萄糖酸杆菌发酵周期的方法
CN116903543A (zh) * 2023-09-08 2023-10-20 重庆普佑生物医药有限公司 一种瑞舒伐他汀钙的制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3863170A (en) 1973-02-21 1975-01-28 Bendix Corp Thermally stable power amplifier
DE2401055A1 (de) 1974-01-10 1975-07-24 Horst Lindenmann Spielgeraet
US5567605A (en) 1994-11-21 1996-10-22 Uop Assay for D-allose using a NAD cofactor coupled D-allose dehydrogenase
WO2002034919A1 (en) 2000-10-27 2002-05-02 Roche Diagnostics Gmbh Variants of soluble pyrroloquinoline quinone-dependent glucose dehydrogenase
US7414119B2 (en) 2002-09-20 2008-08-19 Verenium Corporation Aldolases, nucleic acids encoding them and methods for making and using them
JP4415282B2 (ja) 2003-03-24 2010-02-17 東洋紡績株式会社 基質特異性または安定性に優れたピロロキノリンキノン(pqq)依存性グルコースデヒドロゲナーゼ改変体
EP1751287A2 (en) 2004-06-04 2007-02-14 DSMIP Assets B.V. Improved 2-deoxy-d-ribose 5-phosphate aldolases (deras) and the uses thereof
WO2006008132A1 (en) 2004-07-20 2006-01-26 Roche Diagnostics Gmbh Genetically engineered pyrroloquinoline quinone dependent glucose dehydrogenase comprising an amino acid insertion
ES2537106T3 (es) 2004-10-15 2015-06-02 F. Hoffmann-La Roche Ag Mutantes termoestables de la glucosa deshidrogenasa dependiente de quinona de pirroloquinolina
JP2006217811A (ja) 2005-02-08 2006-08-24 Toyobo Co Ltd 基質特異性に優れたピロロキノリンキノン(pqq)依存性グルコースデヒドロゲナーゼ改変体
CA2612293A1 (en) 2005-06-16 2006-12-21 Pfizer Inc. Process for producing atorvastatin, pharmaceutically acceptable salts thereof and intermediates thereof
EP1969131A1 (en) * 2005-12-15 2008-09-17 Isobionics B.V. Process for the preparation of delta lactones
CA2649135C (en) 2006-04-13 2013-11-19 F. Hoffmann-La Roche Ag Improved mutants of pyrroloquinoline quinone dependent soluble glucose dehydrogenase
US8183397B2 (en) 2007-04-03 2012-05-22 Lek Pharmaceuticals D.D. Synthesis of statins
US7947483B2 (en) * 2007-08-10 2011-05-24 Genomatica, Inc. Methods and organisms for the growth-coupled production of 1,4-butanediol
US8404870B2 (en) * 2008-01-23 2013-03-26 Lek Pharmaceuticals D.D. ((2S,4R)-4,6-dihydroxytetrahydro-2H-pyran-2-yl)methyl carboxylate and process for the production thereof
DE102008030435A1 (de) 2008-06-26 2010-01-07 Bayer Technology Services Gmbh Neuartige Varianten PQQ-abhängiger Glukosehydrogenase mit verbesserter Substratspezifität
WO2013068917A1 (en) * 2011-11-07 2013-05-16 Dr. Reddy's Laboratories Limited Processes for the production of a lactone statin intermediate by enzymatic oxidation

Similar Documents

Publication Publication Date Title
Goldberg et al. Biocatalytic ketone reduction—a powerful tool for the production of chiral alcohols—part II: whole-cell reductions
EP2025760A1 (en) Method of producing hydroxycarboxylic acid by regenerating coenzyme
CN101372699B (zh) 一种羰酰还原酶在生产(s)-4-氯-3羟基丁酸乙酯中的应用
RU2634120C2 (ru) Ферментативный путь для получения левулиновой кислоты, левулинатных сложных эфиров, валеролактона и их производных
Yamamoto et al. Synthesis of ethyl (R)-4-chloro-3-hydroxybutanoate with recombinant Escherichia coli cells expressing (S)-specific secondary alcohol dehydrogenase
JP2014501524A5 (enExample)
Liljeblad et al. Biocatalysis in the preparation of the statin side chain
JP2015535426A (ja) CYP153アルカンヒドロキシラーゼを使用したアルカンまたは1−アルカノールからのα,ω−ジオールの製造方法
CN104726507A (zh) 一种醛酮还原酶在催化生成(r)-4-氯-3羟基丁酸乙酯中的应用
Guevara-Martínez et al. The role of the acyl-CoA thioesterase “YciA” in the production of (R)-3-hydroxybutyrate by recombinant Escherichia coli
EP3230462B1 (en) Genetically modified phenylpyruvate decarboxylase, processes to prepare, and uses thereof
Ye et al. A review—biosynthesis of optically pure ethyl (S)-4-chloro-3-hydroxybutanoate ester: recent advances and future perspectives
Cheng et al. A high-efficiency artificial synthetic pathway for 5-aminovalerate production from biobased L-lysine in Escherichia coli
EP1748076A1 (en) Process for producing hydroxycarboxylic acid
CN101392225B (zh) 一种不对称转化制备(s)-4-氯-3-羟基丁酸乙酯的重组酵母菌及其构建方法和应用
Wang et al. 2-Hydroxyisovalerate production by Klebsiella pneumoniae
Huo et al. Hydroxytyrosol production from l-DOPA by engineered Escherichia coli co-expressing l-amino acid deaminase, α-keto acid decarboxylase, aldehyde reductase and glucose dehydrogenase with NADH regeneration
CN103820375B (zh) 一种生物法生产阿魏酸工程菌株及其构建方法
JP5090910B2 (ja) 光学活性2−(n−置換アミノメチル)−3−ヒドロキシ酪酸エステル類の製造方法
ES2926950T3 (es) Procesos para preparar 2-cetoácidos alargados y compuestos C6-C10 a partir de estos mediante modificaciones genéticas de rutas metabólicas microbianas
CN104928224B (zh) 一种阿魏酸生产工程菌株、构建方法及生物转化方法
JP5713333B2 (ja) ジヒドロキシアセトンの製造方法
JP2010532992A (ja) 3,4−エポキシ酪酸エチルの微生物速度論的分割
KR101974221B1 (ko) 유기산 생산을 위한 재조합 미생물 및 이를 이용한 유기산 제조방법
JP5474280B2 (ja) 光学活性なtrans体含窒素環状β−ヒドロキシエステルの製造方法